… Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary
fibrosis. Am J Respir Crit Care Med 194:989–97. The American Journal of Respiratory and …

… The importance of dysregulation of alveolar epithelial cells in the initiation of pulmonary
fibrosis has been strengthened by the recent observation that an IPF-associated mutation in the …

… This review focuses on the roles of GPCR signaling in progression and resolution of
pulmonary fibrosis, and as targets for therapeutic intervention. Although not a focus of this review, …

… In this review, we provide an overview of the current FDA-approved therapies in PAH and …
therapeutic approaches in the area of PAH, we also focus on the latest promising therapies …

… results propose adelmidrol as a therapeutic approach in the treatment of pulmonary fibrosis.
… adelmidrol as a therapeutic approach in the treatment of pulmonary fibrosis. We have …

… However, as these agents are not curative, new therapeutic approaches are needed [7] …
are essential for the development of effective IPF therapies. A number of processes and factors, …

… , it still provides a significant research direction for combination therapy of pulmonary fibrosis.
… These clinical trials indicate that combination therapies for pulmonary fibrosis still need to …

… ILAs are correlated with histologic evidence of pulmonary fibrosis (4) and with demographic
and … Further progress in this area will likely inform novel therapeutic approaches in IPF. …

… However, we are some distance from realising effective therapeutic approaches that are
capable of stopping the disease process, where disease progression still occurs in most IPF …

… the current clinical approaches for IPF and … pulmonary fibrosis. Although these findings
are controversial and require further validation, LOX/LOXL1/LOXL2 as potential therapeutic …